DEF 14A

Company

SELLAS Life Sciences Group, Inc.

Filed

May 31, 2011

Period of Report

July 15, 2011

Accession Number

0000950123-11-055274

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →